Market research
7743.TSE SEED Co.,Ltd
TSE JPY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 16B
- P/E ratio
- 14.22
- Analyst target
- Not available
- Dividend yield
- 2.8%
- Beta
- -0.15
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- JP3347000006
- Market cap
- 16B
- P/E ratio
- 14.22
- Analyst target
- Not available
- Dividend yield
- 2.8%
- Beta
- -0.15
About
About SEED Co.,Ltd
SEED Co.,Ltd. manufactures and sells contact lenses and care products in Japan. The company offers daily disposable contact lenses; bi-weekly/monthly contact lenses or monthly replacement; astigmatic and bifocal contact lenses; astigmatic and bifocal contact lenses; rigid gas permeable contact lenses; and medical contact lenses, including orthokeratology and iris lens. It also provides multipurpose solution (MPS) for soft contact lenses; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products. SEED Co.,Ltd. was incorporated in 1957 and is headquartered in Tokyo, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 7743.TSE discussion.
5 years, 5 months ago
SEED Co.,Ltd is currently in a long term uptrend where the price is trading 12.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
SEED Co.,Ltd's total revenue rose by 6.6% to $8B since the same quarter in the previous year.
Its net income has increased by 312.4% to $593M since the same quarter in the previous year.
Finally, its free cash flow grew by 215.9% to $1B since the same quarter in the previous year.
Based on the above factors, SEED Co.,Ltd gets an overall score of 5/5.